Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Michael Cline

Vascular & Interventional Radiology Columbus, OH Medical Doctor

NPI 1629338645 CMS profile 4222384

395 W 12Th Ave Fl 4, Columbus, OH 43210

Open in the dashboard

General payments

$35,017

60 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Michael Cline of Columbus, OH is reported in the CMS Open Payments database as having received $35,017 across 60 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 89th percentile of Vascular & Interventional Radiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $416 4
2024 General $15,153 25
2023 General $629 8
2022 General $18,762 21
2021 General $20 1
2019 General $39 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Michael Cline
  • Vascular & Interventional Radiology median
  • Middle half of Vascular & Interventional Radiology
  • National median

In program year 2025, general payments to Michael Cline were reported at $416. Among 3,393 Vascular & Interventional Radiology profiles paid that year, the median was $534 and the middle half received between $166 and $2,075.

Show as a table
Year Michael Cline Vascular & Interventional Radiology median Middle half National median
2019 $39 $422 $125–$1,555 $163
2020 $0 $200 $68–$652 $114
2021 $20 $280 $99–$866 $132
2022 $18,762 $433 $137–$1,497 $149
2023 $629 $506 $152–$2,019 $160
2024 $15,153 $556 $175–$1,930 $164
2025 $416 $534 $166–$2,075 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Boston Scientific Corporation $33,709 43 payments
  2. Surefire Medical, Inc. $508 7 payments
  3. Inari Medical, Inc. $201 1 payment
  4. Canon Medical Systems USA, Inc. $176 1 payment
  5. Terumo Medical Corporation $153 2 payments
  6. W. L. Gore & Associates, Inc. $130 1 payment
  7. Argon Medical Devices, Inc. $47 2 payments
  8. Cook Medical LLC $39 1 payment
  9. Imperative Care, INc $35 1 payment
  10. Takeda Pharmaceuticals U.S.A., Inc. $20 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $29,538 18 payments
  2. Travel and Lodging $2,967 9 payments
  3. Food and Beverage $2,513 33 payments
Products named General payments · program years 2019–2025
  1. General - Therapies $18,063 15 payments
  2. SpyGlass Discover $14,623 15 payments
  3. TRINAV INFUSION SYSTEM $508 7 payments
  4. TheraSphere Y90 Glass Microspheres 10 GBq $266 4 payments
  5. FLOWTRIEVER CATHETER, S $201 1 payment
  6. CT THROMBECTOMY SYSTEM KIT $201 1 payment
  7. INTERVENTIONAL ANGIOGRAPHY SYSTEM $176 1 payment
  8. Azur CX Detachable $153 2 payments
  9. GORE VIATORR TIPS Endoprosthesis $130 1 payment
  10. TheraSphere Y90 Glass Microspheres 7.0 GBq (US Commercial) $126 1 payment
  11. Other $201 7 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Billing to Medicare

Part B · data year 2024 · 105 billing codes

Paid by Medicare

$32,620

Medicare's payments for the services billed

Medicare patients

234

Average age 71

Services billed

466

127 women, 107 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Chronic kidney disease 54%
Arthritis 53%
Diabetes 44%
Ischemic heart disease 44%
Heart failure 39%
Depression 34%
COPD 32%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

60 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record